Skip to content

Boston Scientific BSX Net Change in Cash

Net Change in Cash at other companies

Abbott logo
AbbottABT
-$1.72B-58.6%
TFX
TeleflexTFX
-$84.85M-734%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Stryker logo
StrykerSYK
-$1.13B+14.9%
Haemonetics logo
HaemoneticsHAE
-$117.93M
CONMED logo
CONMEDCNMD
-$5.79M-152%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$63.44B-56.6%
P/E17.8×-40.8×
P/S3.1×-4.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's net change in cash?
Boston Scientific (BSX) reported net change in cash of -$504M in Q1 2026.
How has Boston Scientific's net change in cash changed year-over-year?
Boston Scientific's net change in cash decreased by 260.5% year-over-year, from $314M to -$504M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.